An unusual pattern of peritubular capillary injury involving apoptosis in a renal transplant patient

References

• von Rossum A, Laher I, Choy J. Immune-mediated vascular injury and dysfunction in transplant arteriosclerosis. Front Immunol. 2015;5:684. doi:10.3389/fimmu.2014.00684.
   PubMed Web of Science ®Google Scholar
• Haas M. Evolving criteria for the diagnosis of antibody-mediated rejection in renal allografts. Curr Opin Nephrol Hypertens. 2017;26: 1–7.
   PubMed Web of Science ®Google Scholar
• Djamali A, Kaufman D, Ellis T, et al. Diagnosis and management of antibody-mediated rejection: current status and novel approaches. Am J Transplant. 2014;14:255–271. doi:10.1111/ajt.12589.
   PubMed Web of Science ®Google Scholar
• Jiang X, Sung Y, Tian W, et al. Graft microvascular disease in solid organ transplantation. J Mol Med. 2014;92:797–810. doi:10.1007/s00109-014-1173-y.
   PubMed Web of Science ®Google Scholar
• Remport A, Ivanyi B, Mathe Z, et al. Better understanding of transplant glomerulopathy secondary to chronic antibody-mediated rejection. Nephrol Dial Transplant. 2015;30(11):1825–1833. doi:10.1093/ndt/gfu371.
   PubMed Web of Science ®Google Scholar
• Ivanyi B, Kemeny E, Rago P, et al. Peritubular capillary basement membrane changes in chronic renal allograft rejection. Virchows Arch. 2011;459:321–330. doi:10.1007/s00428-011-1114-x.
   PubMed Web of Science ®Google Scholar
• Sis B, Jhangri G, Riopel J, et al. A new diagnostic algorithm for antibody-mediated microcirculation inflammation in kidney transplants. Am J Transplant. 2012;12:1168–1179. doi:10.1111/j.1600-6143.2011.03931.x.
   PubMed Web of Science ®Google Scholar
• Liapis G, Singh H, Derebail V, et al. Diagnostic significance of peritubular capillary basement membrane multilaminations in kidney allografts: old concepts revisited. Transplantation. 2012;94:620–629. doi:10.1097/TP.0b013e31825f4df4.
   PubMed Web of Science ®Google Scholar
• Boren J, Brindle K. Apoptosis-induced mitochondrial dysfunction causes cytoplasmic lipid droplet formation. Cell Death Differ. 2012;19:1561–1570. doi:10.1038/cdd.2012.34.
   PubMed Web of Science ®Google Scholar
• Amiri F. Microparticles in kidney diseases: focus on kidney transplantation. Ren Replace Ther. 2017;3:2–18.
   Google Scholar
• Kinsey G, Okusa M. Pathogenesis of acute kidney injury: foundation for clinical practice. Am J Kidney Dis. 2011;58(2):291–301. doi:10.1053/j.ajkd.2011.02.385.
   PubMed Web of Science ®Google Scholar
• Ito H, Kasaqi N, Shomori K, et al. Apoptosis in the human allografted kidney. Analysis by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling. Transplantation. 1995;60(8):794–798. doi:10.1097/00007890-199510270-00006.
   PubMed Web of Science ®Google Scholar
• Wever P, Aten J, Rentenaar R, et al. Apoptotic tubular cell death during acute renal allograft rejection. Clin Nephrol. 1998;49(1):28–34.
   PubMed Web of Science ®Google Scholar
• Matsuno T, Nakagawa K, Sasaki H. Apoptosis in acute tubular necrosis and acute renal allograft rejection. Transplant Proc. 1994;26:2170–2173.
   PubMed Web of Science ®Google Scholar
• Drachenberg C, Papadimitriou J, Wali R, et al. BK polyomavirus allograft nephropathy: ultrastructural features from viral cell entry to lysis. Am J Transplant. 2003;3:1383–1392. doi:10.1046/j.1600-6135.2003.00237.x.
   PubMed Web of Science ®Google Scholar
• Sedger L, McDermott M. TNF and TNF-receptors: from mediators of cell death and inflammation to therapeutic giants - past, present and future. Cytokine Growth Factor Rev. 2014;25:453–472. doi:10.1016/j.cytogfr.2014.07.016.
   PubMed Web of Science ®Google Scholar
• Maury C, Teppo A-M. Raised serum levels of cachectin/tumor necrosis factor-alpha in renal allograft rejection. J Exp Med. 1987;166:1132–1137. doi:10.1084/jem.166.4.1132.
   PubMed Web of Science ®Google Scholar
• Poon I, Lucas C, Rossi A, et al. Apoptotic cell clearance: basic biology and therapeutic potential. Nat Rev Immunol. 2014;14(3):166–180. doi:10.1038/nri3607.
   PubMed Web of Science ®Google Scholar
• Gullstrand B, Martensson U, Sturfelt G, et al. Complement classical pathway components are all important in clearance of apoptotic and secondary necrotic cells. Clin Exp Immunol. 2009;156(2):303–311. doi:10.1111/j.1365-2249.2009.03896.x.
   PubMed Web of Science ®Google Scholar
• Vives-Pi M, Rodrıguez-Fernandez S, Pujol-Autonell I. How apoptotic beta-cells direct immune response to tolerance or to autoimmune diabetes: a review. Apoptosis. 2015;20:263–272. doi:10.1007/s10495-015-1090-8.
   PubMed Web of Science ®Google Scholar
• Kimani S, Geng K, Kasikara C, et al. Contribution of defective PS recognition and efferocytosis to chronic inflammation and autoimmunity. Front Immunol. 2014;5:566. doi:10.3389/fimmu.2014.00566.
   PubMed Web of Science ®Google Scholar
• Yung S, Chan T. Mechanisms of kidney injury in lupus nephritis - the role of anti-dsDNA antibodies. Front Immunol. 2015;6(475):1–11. doi:10.3389/fimmu.2015.00475.
   PubMed Web of Science ®Google Scholar
• Bromfield M, McQuillan R, John R, et al. The significance of tubuloreticular inclusions as a marker of systemic stimulation by interferons in a case of focal and segmental glomerulosclerosis associated with cytomegalovirus (CMV) infection. Clin Kidney J. 2014;7:174–178. doi:10.1093/ckj/sft156.
   PubMedGoogle Scholar
• Stegall M, Chedid M, Cornell L. The role of complement in antibody-mediated rejection in kidney transplantation. Nat Rev Nephrol. 2012;8(11):670–678. doi:10.1038/nrneph.2012.212.
   PubMed Web of Science ®Google Scholar
• Franzese O, Mascali A, Capria A, et al. Regulatory T-cells in the immunodiagnosis and outcome of kidney allograft rejection. Clin Dev Immunol. 2013;852395:1–7. doi:10.1155/2013/852395.
   Google Scholar
• Darling V, Hauke R, Tarantolo S, et al. Immunological effects and therapeutic role of C5a in cancer. Expert Rev Clin Immunol. 2015;11(2):255–263.
   Google Scholar
• Hogan J, Markowitz G, Radhakrishnan J. Drug-induced glomerular disease: immune-mediated injury. Clin J Am Soc Nephrol. 2015;10(7):1300–1310. doi:10.2215/CJN.01910215.
   PubMed Web of Science ®Google Scholar
• Piga M, Chessa E, Ibba V, et al. Biologics-induced autoimmune renal disorders in chronic inflammatory rheumatic diseases: systematic literature review and analysis of a monocentric cohort. Autoimmun Rev. 2014;13(8):873–879. doi:10.1016/j.autrev.2014.05.005.
   PubMed Web of Science ®Google Scholar
• Bomback A. Eculizumab in the treatment of membranoproliferative glomerulonephritis. Nephron Clin Pract. 2014;128:270–276. doi:10.1159/000368592.
   PubMedGoogle Scholar
• Thurman J. Many drugs for many targets: novel treatments for complement-mediated glomerular disease. Nephrol Dial Transplant. 2017;32:57–64. doi:10.1093/ndt/gfw228.
   Web of Science ®Google Scholar